QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 allurion-highlights-peer-reviewed-publication-on-consecutive-use-of-allurion-smart-capsule

Multicenter study across six countries demonstrates safety and efficacy of two consecutive treatments in adults with obesityWei...

 watching-allurion-technologies-shares-see-volume-to-the-upside-traders-circulate-x-post-saying-new-publication-in-the-obesity-surgery-journal-about-the-allurion-swallowable-gastric-balloon-program-titled-weight-loss-maintenance-1-year-after-the-swallowable-gastric-balloon-results-from-an-international-multicenter-study

https://link.springer.com/article/10.1007/s11695-025-08074-2

 allurion-technologies-presents-study-on-increasing-muscle-mass-and-decreasing-fat-mass-in-patients-treated-with-allurion-program-at-soffcomm

In 1,962 patients treated in France with the Allurion Program, muscle mass as a percentage of total body weight increased, on a...

 allurion-technologies-q1-adj-eps-024-beats-858-estimate-sales-558m-beat-550m-estimate

Allurion Technologies (NYSE:ALUR) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION